Express Scripts’ Proposed Acquisition of Caremark: An Antitrust White Paper

In this White Paper, the AAI urges the FTC to issue a second request and conduct a thorough investigation of Express Scripts’ proposed acquisition of Caremark. The paper discusses potential anticompetitive effects of combining two of the largest Pharmaceutical Benefit Management firms in the U.S.

Click here to view the white paper.